TY  - CHAP
M1  - Book, Section
TI  - Lab/Drug Interactions and Drugs of Abuse
A1  - Buening, Natalie R.
A2  - Attridge, Rebecca L.
A2  - Miller, Monica L.
A2  - Moote, Rebecca
A2  - Ryan, Laurajo
Y1  - 2013
N1  - 
T2  - Internal Medicine: A Guide to Clinical Therapeutics
AB  - Table  Graphic  Jump  LocationTable  E-1  Drugs  of  Abuse:  Urine  Detection  Time*View  Table||Download  (.pdf)Table  E-1  Drugs  of  Abuse:  Urine  Detection  Time*(Mayo  Clin  Proc  2008;83:66;  Chyka  PA.  Substance  abuse  and  toxicological  tests.  Interpreting  Laboratory  Data  3rd  ed.  Bethesda,  MD:  American  Society  of  Health  System  Pharmacists,  2004)DrugTimeAmphetamines48h–2wkLong-term  use  =  2wkBarbiturates24h–4wkLong-acting  (phenobarbital)  =  4wkBenzodiazepines72h–4wkLong-acting  (diazepam)  =  4wkCocaine12–96hCannabinoids72h–  >4wkSingle  use  =  72h;  moderate  use  =  1wk;  daily  use  =  2wk;  long-term  use  ≥  4wkOpioids48h–1wkAssay  specific  for  morphine  with  varying  cross-reactivity  for  semisynthetic/synthetic  opioidsSustained  release  formulations  =  1wkPhencyclidine1wk–  >4wkLong  term  use  =  >4wk*Detection  times  affected  by  PK,  metabolites,  dose,  route,  time  of  last  ingestion,  body  mass,  urine  pH.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=57296396
ER  -